Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar flat to slightly up ahead of Fed guidance

Wed, 17th Mar 2021 15:08

* U.S. 10-year yields jump to 13-month high
* Fed 2023 rates projections under scrutiny
* Euro may be hampered by delay in vaccine rollouts
* Rouble falls after Biden issues warning on Putin
* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

(Adds new comment, FX table, updates prices, changes byline, dateline; previous LONDON)
By Gertrude Chavez-Dreyfuss
NEW YORK, March 17 (Reuters) - The U.S. dollar was flat to slightly higher on Wednesday, with 10-year
Treasury yields hitting fresh 13-month highs ahead of the outcome of a Federal Reserve policy meeting which
could shed some light on the timing of future rate hikes and the central bank's tolerance for rising yields.
With Fed policymakers expected to forecast the fastest U.S. economic growth in decades in the wake of
COVID-19 vaccinations and $1.9 trillion in new stimulus, market participants will be focused on clues that
the central bank could start raising rates in 2023, earlier than it had said.
"The spike in U.S. yields dictated the positioning before the Fed," said Edward Moya, senior market
analyst, at online FX broker OANDA.
"The market is anticipating a much more optimistic outlook by the Fed and with that you're going to get
higher Treasury yields, and that would be supportive for the dollar," he added.
The U.S. benchmark 10-year note yield rose to a 13-month peak of 1.676% and was last up at
1.655%.
Ahead of the Fed statement later on Wednesday, eurodollar futures, which track short-term rate
expectations, have priced a 90% chance of a rate hike by December 2022, with three hikes seen in 2023.
In mid-morning trading, the dollar index was flat at 91.865.
The euro was up 0.1% at $1.1912, after declining in the past three sessions.
Hurt by a possible delay in the European Union's vaccination effort, the euro seemed set to test last
week's 3-1/2-month low of $1.1835.
Europe's medicines watchdog will release results of its investigation into incidents of bleeding, blood
clots and low platelet counts in recipients of AstraZeneca's coronavirus vaccine on Thursday
afternoon.
Europe's painful recovery from the pandemic is in sharp contrast with other economies, which seem less
dependent on monetary stimulus to pull though.
The Bank of Canada for instance is likely to reduce its bond purchases as soon as next month,
strategists say.
The rouble fell 1.3% against the greenback to 73.78 per dollar, after U.S. President Joe
Biden said Russian President Vladimir Putin would face consequences for directing efforts to swing the 2020
U.S. presidential election to Donald Trump.
Against the yen, the greenback firmed 0.2% to 109.17 yen, hovering near nine-month highs hit this
week.
The British pound was flat at $1.3896%, recovering from profit-taking after it hit a near
three-year high last month on the back of a fast vaccine roll-out.
Commodity-linked currencies including the Australian dollar, the New Zealand dollar and
the Canadian dollar traded lower against the U.S. dollar.
In the cryptocurrency market, bitcoin fell 3.4% to $54,978.00, slipping further away from a
record high of $61,781.83 hit on Saturday.

========================================================
Currency bid prices at 10:44AM (1444 GMT)
Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid
Previous Change
Session
Dollar index 91.8880 91.8730 +0.03% 2.119% +91.9930 +91.8180
Euro/Dollar $1.1910 $1.1903 +0.06% -2.52% +$1.1917 +$1.1887
Dollar/Yen 109.1800 109.0200 +0.14% +5.69% +109.2450 +109.0650
Euro/Yen 130.02 129.75 +0.21% +2.44% +130.0500 +129.7200
Dollar/Swiss 0.9277 0.9248 +0.32% +4.87% +0.9296 +0.9248
Sterling/Dollar $1.3892 $1.3895 +0.00% +1.71% +$1.3929 +$1.3880
Dollar/Canadian 1.2476 1.2448 +0.22% -2.03% +1.2479 +1.2434
Aussie/Dollar $0.7721 $0.7746 -0.32% +0.37% +$0.7747 +$0.7711
Euro/Swiss 1.1049 1.1007 +0.38% +2.22% +1.1061 +1.1006
Euro/Sterling 0.8572 0.8567 +0.06% -4.08% +0.8573 +0.8541
NZ $0.7169 $0.7190 -0.28% -0.15% +$0.7194 +$0.7158
Dollar/Dollar
Dollar/Norway 8.5020 8.4700 +0.16% -1.21% +8.5125 +8.4785
Euro/Norway 10.1257 10.0967 +0.29% -3.26% +10.1330 +10.0840
Dollar/Sweden 8.5070 8.4960 +0.27% +3.81% +8.5298 +8.4968
Euro/Sweden 10.1333 10.1058 +0.27% +0.56% +10.1465 +10.1140


(Reporting by Gertrude Chavez-Dreyfuss; Additional reporting by Julien Ponthus and Marc Jones in London;
Editing by Giles Elgood and Andrea Ricci)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.